Wed 11/14/2018 19:25 ET
S&P 5002701.5820.530.76%BANKS439.907.391.68%OIL55.950.300.54%BITCOIN5715.1525.150.44%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - India Globalization Capital - IGC   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IGC
From: NetworkNewsWire (Rep: 0)Date: 11/02/2017 18:59
Forum: India Globalization Capital - Msg #1233Thread #673963165 (Rec: 0)
NetworkNewsBreaks – India Globalization Capital (NYSE: IGC) Aims to Fast-Track Release of Hyalolex in Recreational Cannabis States

As a first mover in the cannabis-based combination therapy space, India Globalization Capital (NYSE AMERICAN: IGC) is preparing for the launch of its breakthrough treatment aimed at reducing beta-amyloid building up in Alzheimer’s patients, Hyalolex. The classification as a combination therapy enables the company to bring the product to market significantly faster than most pharmaceuticals, because Hyalolex does not need FDA approval. An article discussing this reads: “This hugely accelerated introduction of Hyalolex can only be accomplished in states where medical cannabis is legal and where the ailment (in this case Alzheimer’s) is an approved medical condition. In states where recreational cannabis has been approved, IGC doesn’t have to contend with whether or not Alzheimer’s is an approved medical condition in order to bring its treatment to market. Therefore, these states (recreational marijuana states like California, Colorado, Oregon, etc.) will be targeted first with IGC’s cannabis-based Alzheimer’s treatment.”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser NetworkNewsWire: Reward | Watch | IgnoreIGC: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IGC | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999-, Inc.